Showing results (41-50 of 1,192) with videos related to
Sort By:
Pageof 120
Pediatric Transplantation|September 18, 2002
Application of MARS artificial liver support as bridging therapy before split liver retransplantation in a 15-month-old childM Hommann, L B Kasakow, J Geoghegan, et al.Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1978
Specificities of heterologous antisera against human leukaemia cells. 1. Reactions against leukaemia cellsH Thränhardt, J Milleck, F Zintl, et al.Klinische Padiatrie|June 18, 1998
[Heparin-induced type II thrombocytopenia within the scope of high dose chemotherapy with subsequent stem cell rescue]M Sauer, B Gruhn, D Fuchs, et al.Kinderarztliche Praxis|November 1, 1991
[Therapy of acute myeloid leukemia in children--results of the AML II/87 multicenter study]J Hermann, F Zintl, M Krause, et al.Bone Marrow Transplantation|June 5, 1998
Cyclosporin A-induced graft-versus-host disease following autologous bone marrow and stem cell transplantation in hematological malignancies of childhoodB Gruhn, R Häfer, H Kosmehl, et al.Pediatric Hematology and Oncology|June 6, 1998
Complete recovery of renal function in a Wilms' tumor patient after acute renal failure caused by autologous bone marrow transplantation (ABMT)L Hempel, L Patzer, J Misselwitz, et al.Klinische Padiatrie|March 17, 2000
[Procalcitonin in comparison to C-reactive protein as markers of the course of sepsis in severely immunocompromised children after bone marrow transplantation]M Sauer, K Tiede, R Volland, et al.Bone Marrow Transplantation|June 11, 2003
Procalcitonin, C-reactive protein, and endotoxin after bone marrow transplantation: identification of children at high risk of morbidity and mortality from sepsisM Sauer, K Tiede, D Fuchs, et al.Bone Marrow Transplantation|January 31, 2006
Elevated serum insulin-like growth factor binding protein-2 is associated with a high relapse risk after hematopoietic stem cell transplantation in childhood AMLK Dawczynski, E Kauf, D Schlenvoigt, et al.Leukemia|July 30, 2002
BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemiaD Steinbach, W Sell, A Voigt, et al.Pageof 120